ArticleAmerican journal of cancer research2020

ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.

Xueqiang Deng et al.PubMed ↗Full text ↗

No numbers read from the abstract.